Hypermethylation and prognostic implication of Syk gene in human colorectal cancer
Hypermethylation and prognostic implication of Syk gene in human colorectal cancer
复制标题
Syk 基因在人类结直肠癌中的高甲基化及其预后意义
DOI:
10.1007/s12032-013-0586-8
复制
发表时间:
2013-04
期刊:
影响因子:
3.4
通讯作者:
Yuan, Yunfei
中科院分区:
文献类型:
--
作者:
Wang, Jianping;Huo, Lijun;Chen, Hao;Ni, Beibei;Xiang, Jun;Kang, Liang;Wang, Lei;Peng, Junsheng;Yuan, Yunfei
The study was aimed to investigate the relationship between hypermethylation of Syk gene and clinicopathological characteristics and long-term outcomes in colorectal cancer. The effect of Syk on cell proliferation and invasion ability was also assessed. Methylation and expression status of Syk were explored in CRC tissues and cell lines by MSP, qRT-PCR and western blot assay. The effects of Syk overexpression on tumorigenesis were studied by in vitro assay. The correlation between Syk methylation and clinical relevance in CRC patients was also analyzed. Syk methylation was found 48.6 % in CRC tissue samples and 57.1 % in cell lines, respectively. The loss of Syk expression could be restored by demethylation agent. Overexpression of Syk in CRC cell inhibited cell proliferation (p< 0.01) and invasion (p< 0.01). The methylation of Syk was significantly associated with histological grade (p= 0.002), lymph node status (p< 0.001) and TNM stage (p< 0.001). Five-year overall survival in methylated Syk group was significantly lower than that in unmethylated Syk group (59 vs. 80 %,p< 0.001). Multivariate analysis demonstrated that Syk methylation was an independent prognostic factor for overall survival. Syk is identified as a potential tumor suppressor in CRC progression. Syk methylation is correlated with poor overall survival, which acts as an independent prognostic indicator of CRC.
登录
查看更多内容
影响因子:
11.2
作者:
Yunfei Yuan;Richard Mendez;Aysegul A. Sahin;J. Dai
通讯作者:
Yunfei Yuan;Richard Mendez;Aysegul A. Sahin;J. Dai
DOI:
10.1200/jco.1998.16.2.793
发表时间:
1998-02
期刊:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
影响因子:
--
作者:
R. Bast;C. Desch;D. Hayes;N. Kemeny;P. Ravdin;M. Somerfield;Thomas J. Smith
通讯作者:
R. Bast;C. Desch;D. Hayes;N. Kemeny;P. Ravdin;M. Somerfield;Thomas J. Smith
影响因子:
6.4
作者:
Ogane, Satoru;Oncla, Takeshi;Shibahara, Takahiko
通讯作者:
Shibahara, Takahiko
影响因子:
2.7
作者:
Tsuchida, S;Yanagi, S;Yamamura, H
通讯作者:
Yamamura, H
DOI:
10.1186/bcr261
发表时间:
2001
期刊:
Breast cancer research : BCR
影响因子:
--
作者:
Stewart ZA;Pietenpol JA
通讯作者:
Pietenpol JA